auto_awesome_motion View all 3 versions
organization

Bayer AG

BAYER AKTIENGESELLSCHAFT
Country: Germany
66 Projects, page 1 of 14
  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 956146
    Overall Budget: 2,790,440 EURFunder Contribution: 2,790,440 EUR
    Partners: Roche (Switzerland), University of Greifswald, KUL, Bayer AG, MERCK HEALTHCARE KGAA, UoA

    The advanced age population (>65y) makes up ~20% of the total population in Europe, is the main carrier of chronic diseases and the major end-user group of medications. Yet, despite an ageing society, these end-users are entirely disregarded in the drug development proc...

  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 101034439
    Overall Budget: 2,162,500 EURFunder Contribution: 1,000,000 EUR
    Partners: MPG, University of Vienna, University of Liverpool, Leiden University, UOXF, Bayer AG, AXXAM SPA, PFIZER, CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH

    Solute carriers (SLCs) are the largest family of membrane transporters encoded in the human genome and their role in trafficking nutrients, ions, vitamins and cofactors is vital for maintaining homeostasis in individual cells, organs and tissues. Their misfunction is as...

  • Open Access mandate for Publications
    Funder: EC Project Code: 675251
    Overall Budget: 4,090,250 EURFunder Contribution: 4,090,250 EUR
    Partners: RWTH, DTU, ALFA LAVAL COPENHAGEN A/S, Imperial, University of Strathclyde, BAYER TECHNOLOGY SERVICES GMBH, UCBL, Bayer AG, UNILEVER U.K. CENTRAL RESOURCES LIMITED

    The ModLife project is a European Training Network initiative that brings together 5 leading European universities, 4 global industrial players and 2 SMEs to undertake research and training in the area of product-process innovation, optimization monitoring and control f...

  • Open Access mandate for Publications
    Funder: EC Project Code: 871394
    Overall Budget: 499,479 EURFunder Contribution: 499,479 EUR
    Partners: FUTURS HEALTH PRODUCTS SARL, CEA, PHILIPS ELECTRONICS NEDERLAND B.V., Siemens Healthcare GmbH, Delft University of Technology, Bayer AG, IMEC, FHG, ValoTec

    The objective of the HELoS CSA is to support the Health.E Lighthouse Initiative Advisory Service (LIASE) in its ambition to accelerate innovation in medical devices (“Moore for Medical”). Health.E will accelerate the innovation in medical devices and systems by stimulat...

  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 101073386
    Funder Contribution: 2,687,400 EUR
    Partners: MIMETAS, RCSI, UCL, Bayer AG, Heidelberg University, ICM, Luxembourg Institute of Health, geneXplain, ERASMUS MC, VLAAMS INSTITUUT BIOTECHNOLOGIE FLANDERS INSTITUTE FOR BIOTECHNOLOGY

    Isocitrate dehydrogenase wildtype (IDHwt) glioblastoma (GBM) is the most frequent, aggressive and lethal brain tumour. It has a universally fatal prognosis with 85% of patients dying within two years. Effective precision medicine therapies are thus urgently required. Th...